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Review Article 
Is Biopsy Necessary if Colonoscopy is Normal in Patients With Chronic 
Unexplained Diarrhea?
Kunihiko MURASE
Second Department of Internal Medicine, Nagasaki University School of Medicine
 Endoscopy and biopsy are important diagnostic tools 
in the evaluation of patients with chronic diarrhea and 
normal colonic mucosa. When colonoscopy is performed in 
patients with diarrhea and normal endoscopic appearance, 
representative sampling is important to rule out not just 
irritable colon but other conditions such as inflammatory 
bowel disease, collagenous colitis, lymphocytic colitis, 
eosinophilic colitis and amyloidosis. Clinically important 
histological lesions can be identified in a significant 
proportion of patients in spite of normal or nonspecific 
colonoscopic findings, which justifies routine mucosal 
biopsy in the evaluation of patients with chronic diar-
rhea. It is recommended that when colonoscopy is per-
formed for the evaluation of patients with diarrhea of 
unknown cause and mucosa appears normal, five biopsy 
sites be sampled, including the cecum, transverse colon, 
descending colon, sigmoid colon and rectum.
INTRODUCTION
 Diarrheal disease can be divided into acute and 
chronic forms. Acute diarrhea is commonly due to in-
fectious pathogens, is often self-limiting, and most pa-
tients do not require specific therapy (1). In patients 
with chronic diarrheal disease, the individual case his-
tory is of paramount importance for differentiation be-
tween functional and organic illness. At least half of 
patients in the general practice suffer from functional 
rather than organic disease. Endoscopy of the gastroin-
testinal tract is the first-line procedure in patients with 
chronic diarrhea (2). In a large proportion of patients
with chronic diarrhea, colonoscopy may show one or 
more forms of abnormalities ranging from congestion, 
hemorrhage, edema, stenosis, erosions, pseudomembranes, 
and ulceration of the colonic mucosa. A number of 
studies have suggested that colorectal biopsies should 
be routinely obtained at endoscopy in patients with 
normal appearing mucosa who present with chronic 
diarrhea, because significant pathology may be identi 
fied on histopathological examination (3-6). Possible ab-
normalities include inflammatory bowel disease (IBD), 
collagenous colitis, lymphocytic (microscopic) colitis, 
infectious colitis, eosinophilic colitis, amyloidosis, and 
AIDS-associated diarrhea. 
 In Japan, endoscopists tend to diagnose irritable 
bowel syndrome (IBS) when patients with chronic di-
arrhea exhibit normal endoscopic features although no 
colonic biopsy is taken for histopathological examina-
tion. An important issue in the clinical management of 
such patients is, therefore, whether the endoscopist 
should take a biopsy when confronted with an appar-
ently normal colorectal mucosa. 
 The lamina propria of colonic mucosa normally con-
tains lymphocytes, plasma cells, eosinophils, and a few 
neutrophils. Increased number of such cells is consid-
ered to reflect the presence of colonic inflammation. 
However, the number of cells present in the normal 
mucosa has not been clearly established, and patholo-
gists tend to overdiagnose the physiologic inflamma-
tory infiltrate as evidence of colitis and underdiagnose 
specific etiologic types of colitis (7). 
 In this review, I will try to provide the endoscopist 
with insights into why and when to perform a biopsy 
of normally appearing colorectal mucosa in patients 
with chronic diarrhea.
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Crohn's disease
 Crohn's disease is characterized by the presence of 
longitudinal ulcers and aphthous ulcers in the small 
intestine and colon, with non-caseous granuloma for-
mation (Fig. IA). Furthermore, biopsies from macro-
scopically normal mucosa in patients with Crohn's dis-
ease can show diagnostic abnormalities (8, 9). The 
characteristic morphology of mildly active Crohn's dis 
ease in colonic biopsies includes lymphoplasmacytic and 
neutrophilic inflammation and infrequent granulomas 
or giant cells. Inflammation is often patchy and can 
be associated with aphthoid ulcer, and therefore, multi-
ple biopsies and serial sections are recommended for 
the diagnosis of Crohn's disease (10). There is usually 
glandular architectural distortion (11). 
 Focal cryptitis is often detected in the colonic 
mucosa of patients with Crohn's disease (Fig. 1B), 
which may represent an early stage in the evolution 
of Crohn's disease (12, 13). However, this feature is 
non-specific and may also be seen in ischemia, infec-
tions, partially treated ulcerative colitis (14, 15). This 
emphasizes the importance of obtaining a biopsy from 
apparently uninvolved mucosa, proximal or distal to 
the lesions.
Ulcerative colitis
 Ulcerative colitis affects contiguous areas of the 
colon and is most severe in the rectum, however, 
endoscopic and histological patchiness of inflammation 
and rectal sparing are common during the course of 
the disease in treated ulcerative colitis. Therefore, rec-
tal sparing or patchiness should not necessarily indi-
cate a change in the diagnosis to Crohn's disease (16-
19). A number of investigators have stressed that the 
relapse index is significantly higher in patients with 
rectal sparing (17), however, complete histologic spar-
ing of the rectum is not rare (16). In general, 
endoscopic appearances of ulcerative colitis during the 
resolving or quiescent stages do not correlates well 
with histological findings as they do in the acute 
phase. The mucosa in ulcerative colitis usually regen-
erates so well that it is often virtually indistinguish-
able from the normal mucosa on histological examina-
tion (20,21), however, architectural distortion, which 
indicates previous damage to the involved crypt, is 
often seen (Fig. 2), making it possible to diagnose qui-
escent ulcerative colitis (11). 
 Patients with ulcerative colitis treated by 5-aminosalicylic 
acid (5-ASA) rarely have diarrhea despite the effect of
5-ASA on arachidonic acid metabolism. The incidence of 
diarrhea is 13-20% in olsalazine and 5% in mesalamine-
treated patients (22, 23). Histologically, infiltration of the 
mucosa with eosinophils coalescing in areas to form 
eosinophilic crypt abscesses often correlates with clini-
cal symptoms. The clinical problem is difficult because 
the dose of 5-ASA necessary to control ever-increasing 
disease. When 5-ASA sensitivity is suspected, topical 
challenge may show profound microscopic change dur-
ing a short period of time.
Collagenous colitis
 Collagenous colitis is characterized by chronic wa-
tery diarrhea associated with microscopic mucosal in-
flammation and deposition of collagen below the sur-
face epithelium of the colonic mucosa (Fig. 3-B). 
There are generally no or minimal endoscopic abnor-
malities (Fig. 3-A), and colorectal biopsy is required to 
establish the diagnosis (24). In Japan, this is a very 
rare disease, and we have only encountered one case 
in our institution. This disease predominantly affects 
middle-aged elderly women. Typically, the patient 
presents with a history of chronic, non-bloody, watery 
diarrhea, of up to 20 bowel movements per day, for 
months or years. The etiology of collagenous colitis is 
still unclear, although a variety of associated diseases 
have been reported including gastrointestinal diseases 
such as collagenous sprue (25, 26) as well as systemic dis-
eases such as rheumatic syndromes (27, 28) and thyroid 
diseases (28, 29). Riddell and colleagues (30) indicated 
that non-steroidal anti-inflammatory drugs(NSAIDs) use 
is common among patients with collagenous colitis 
(30). They also warned that in some cases, diarrhea 
followed the use of NSAIDs in all patients and that it 
improved after withdrawal of NSAIDs. Cimetidine 
rarely causes watery diarrhea (31). However, its role 
in the pathogenesis of collagenous colitis remains un-
settled. 
 The thickness of subepithelial collagen deposits has 
been reported by some to be predominant in the right 
colon, especially the transverse colon (32-34), although 
others have not observed this regional variation (35, 
36). The normal subepithelial basement membrane has 
a minimum thickness of 4 p m, but in collagenous co-
litis this sometimes exceeds 30 u m (37). Thickening 
of the collagen plate above 10 p m has been recently 
proposed as the threshold criterion for histological di-
agnosis of collagenous colitis (32, 35). This variability 
in the reported thickness between different groups of 
investigators might be due to several methodological
differences, including fixation, orientation, and methods of 
analysis (38, 39). Goff et al (40) found no significant 
difference in collagen thickness, epithelial damage, lamina 
propria cellularity, or lamina propria eosinophilia between 
patients reporting resolution of clinical symptom and 
those with ongoing symptoms. Conversely, Lee et al (41) 
studied patients with lymphocytic and collagenous colitis 
and found that stool weight correlated with lamina 
propria cellularity but not with collagen thickness. 
 It is important to stress that the perceived thickness 
of the collagen band alone is not sufficient for the di-
agnosis of collagenous colitis. There is almost always 
an associated increase in inflammatory cells such as 
lymphocytes, plasma cells, mast cells and macrophages. 
Mast cells and macrophages are widely distributed 
throughout the gastrointestinal mucosa and form the 
major source of inflammatory mediators. Schwab et al 
(42) reported mast cell activation in collagenous colitis, 
and we found that the numbers of mast cells and 
macrophages were different in patients with collagenous 
colitis than in those with Crohn's disease and ulcerative 
colitis (43). Our results also suggested that collagenous 
colitis is more of Th2 type reaction than Thl. 
 Prognosis varies widely in this disease, and prednisolone 
is most effective with a response rate of 80% (40, 44), 
while that of 5-ASA is 40-60% (45, 46). However, 
treatment-free remissions are common in collagenous 
colitis (47).
Lymphocytic colitis (Microscopic colitis)
 Lymphocytic colitis (LC) is classically described as 
a triad of chronic non-bloody, watery diarrhea, normal 
or near-normal endoscopic findings, and colonic epithelial 
lymphocytosis without thickening of the subepithelial 
collagen table. Read et al (48) reported a mild in-
crease in inflammatory cells in biopsy specimens of a 
number of patients with chronic diarrhea who had in sig-
nificant colonoscopic finding and coined the term "micro-
scopic colitis" to describe this form of diarrheal disease. 
Subsequently, Lazenby et al (49) showed that increased 
number of colonic intraepithelial lymphocytes was the 
major distinguishing feature in many of the patients with 
microscopic colitis and therefore proposed the term 
lymphocytic colitis to identify that subgroup. 
 Normally, there are five or fewer lymphocytes per 
100 epithelial cells, but this is markedly increased in 
lymphocytic colitis to 20-40/100 epithelial cells (Fig. 
4). In this regard, Wang et al (51) proposed that the 
criterion for diagnosis was the presence of at least 15 
surface lymphocytes per 100 epithelial cells. Intraepithelial
lymphocytes in lymphocytic colitis are mostly CD8-posi-
tive (50), and they are overlying lymphoid follicle that 
have an antigen-presenting function, termed M cells. 
 Colonic epithelial lymphocytosis is not only seen in 
lymphocytic colitis (24, 51), but also in collagenous 
colitis (29, 52), as well as in some cases of celiac 
sprue (50, 53). Recently, this histologic finding has 
also been reported in epidemic outbreaks of apparently 
infectious diarrhea, Brainerd diarrhea (54-58). The 
term Brainerd diarrhea has been applied to outbreaks 
of chronic watery diarrhea of unknown etiology char-
acterized by acute onset and prolonged duration. 
Patients are more likely to be travelers with a history 
of drinking unbottled water or ice or consumed raw 
sliced fruits and vegetables washed in unbottled water 
(56-58). Patients with Brainerd diarrhea often do not re-
spond to antimicrobial therapy (57, 58). Colonoscopy in 
these patients show normal mucosa or patchy erythema, 
and colonic biopsy specimens frequently show epithe-
lial lymphocytosis similar to that seen in collagenous 
and lymphocytic colitis. Although Brainerd diarrhea 
can be currently diagnosed only with epidemiologic 
data indicating an epidemic and a point source, the 
lack of surface degenerative changes and the relatively 
lower lymphocyte counts may serve to distinguish it 
from lymphocytic colitis (58).
Infectious colitis
 This is always a possibility and is probably the most 
difficult in the differential diagnosis. It is uncertain if 
these cases can be diagnosed if the full picture of in-
fection is not present on the biopsy, particularly when 
symptoms have been present for weeks or months 
where extension of chronic inflammatory cells, especially 
plasma cells, may be seen down to the muscularis 
mucosae. Further, it should be remembered that 
chronicity does not exclude infection; Clostridium 
difficile may cause symptoms for months if left un-
treated (59), while even patients with infections such 
as Shigellosis and Salmonellosis may occasionally have 
chronic symptoms (60, 61).
Eosinophilic enterocolitis
 Eosinophilic colitis remains a relatively poorly described 
disease entity in which diarrhea and eosinophilic infiltra 
tion of the colon often with peripheral eosinophilia pre 
dominate. The most common pathologic cause of 
eosinophilic accumulation is probably ulcerative colitis,
with numerous eosinophils present in the lamina propria 
(62, 63). In developing countries, parasitic infection such as 
Strongyloides (64), Ancylostoma caninum (65), and dog 
hookworm (66) is often associated with eosinophilic 
accumulation in the colon. Occasional case reports 
have described eosinophilic infiltration as a side-effect 
to several drugs including carbamazepine (67), rifanpicin 
(68), naproxen (69), and azathioprine (70). Serosal in-
volvement is frequently accompanied by eosinophilic 
ascites. Colonic eosinophilia may also be part of the 
generalized eosinophilic vasculitis associated with 
Churg-Straus syndrome (71). In some biopsies from 
patients with these diseases, eosinophils may be promi-
nent particularly beneath the luminal epithelium and 
sometimes within the epithelium (Fig. 5). Eosinophilic 
colitis in these conditions are characterized 
histologically by the presence of > 20 eosinophils per 
high-power field (72, 73).
AIDS-associated diarrhea
 Chronic diarrhea with malabsorption and weight loss is a 
common problem in AIDS patients. The causative organisms 
frequently identified in such cases are cytomegalovirus, 
adenovirus, cryptosporidium, microsporidia, mycobacterium 
avium complex (74, 75). Furthermore, bacterial patho-
gens are more common in AIDS patients than in the 
general population (76). Colonoscopy is commonly per-
formed in patients with chronic human immunodeficiency 
virus (HIV)-related diarrhea after negative stool stud-
ies, and the test often shows normal or mildly in-
flamed mucosa. A pathogen is frequently identified in 
colonic biopsy specimens from patients with HIV-
related chronic diarrhea, and therefore, the test is 
thought to be the most cost-effective diagnostic proce-
dure (77). Microscopic examination shows foci of 
mucosal necrosis containing chronic inflammatory 
cells, degenerating and necrotic epithelial cells with 
amphophilic nuclear inclusions. Transmission electron 
microscopic reveals hexagonal viral particles character-
istic of the causative virus within the nuclear inclu-
sions (78). 
 Another entity known as idiopathic AIDS enteropathy 
is diarrhea in AIDS patients in whom secondary infec-
tious agents cannot be identified. There is evidence to 
suggest that these changes occur in HIV carriers who 
do not exhibit clinical manifestations of AIDS (79).
Amyloidosis
Amyloidosis usually causes various gastrointestinal
symptoms included diarrhea, anorexia, macroglossia, 
and intestinal pseudo-obstruction. Reactive systemic or 
secondary amyloidosis occurs in 1-30% of adults with 
Crohn's disease (80, 81). Colonoscopy commonly shows 
mucosal friability and erosions, but rarely shows nor-
mal appearance of the colonic mucosa. Rectal biopsy 
has the highest diagnostic yield, followed by duodenal, 
gastric, and colonic biopsies. Amyloid deposit is dem-
onstrated principally in blood vessels and accompanies 
microscopic inflammation (82).
Irritable bowel syndrome (IBS)
 IBS is a chronic disorder of the gastrointestinal tract. 
The etiology of irritable bowel syndrome is still un-
clear and the relationship between food and IBS is 
controversial. Psychiatric disorders have an adverse in-
fluence on the outcome of IBS, which is thought to be 
due to the close relationship between psychological 
symptoms and severity of abdominal pain, bloating, 
and diarrhea (83). Familiarity with both the distribu-
tion and intensity of normal inflammation is therefore 
essential, including the facts that (a) normal distribu-
tion of chronic inflammatory cells, particularly plasma 
cells, is limited to the upper two thirds of the mucosa, 
although macrophages, occasional lymphocytes, mast 
cells and eosinophils may invade the muscularis 
mucosae, (b) the severity of chronic inflammation is 
such that other than normal lymphoid aggregates, in-
flammatory cells are not tightly packed against each 
other (11). Few studies reported that rectal biopsy 
and lactose hydrogen breath testing are helpful in es-
tablishing the diagnosis of IBS (84), but their useful-
ness could not be confirmed by others (85, 86). There 
are also a few reports that have described infiltration 
of mast cells in IBS (87, 88), although this remains 
controversial (89).
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Fig. 1. (A) Fig. 3. (B)
Fig. 3. Collagenous colitis. (A) Colonoscopy in sigmoid colon 
showing almost normal colonic mucosa. (B) Thickening of 
subepithelial collagen band with numerous chronic inflammatory 
cells. Magnification, x 100
Fig. 1. (B)
Fig. 1. Crohn's disease. (A) Noncaseous granuloma with 
giant cells. Magnification, X200, (B) Localized acute inflam-
matory process with focal cryptitis in the central area. 
Magnification, x 100 Fig. 4. Lymphocytic colitis; Note the intraepithelial lympho-
cytes with increased chronic inflammatory cells in the lamina 
propria. Magnification, X200
Fig. 2. Quiescent ulcerative colitis; Architectural distortion with-
out neutrophils or basal plasmacytosis. Magnification, X 100
Fig. 5. Eosinophilic colitis. Note the presence of numerous 
eosinophils particularly beneath the luminal epithelium and occa-
sionally in the epithelium. Magnification, X 100
Fig. 3. (A)
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